| Acquirer | Target | Price |
|---|---|---|
| Bio-Techne Corporation | Advanced Cell Diagnostics | $250 million |
| Merit Medical Systems, Inc. | DFINE, Inc. | $97.5 million |
| Bristol-Myers Squibb | Cormorant Pharmaceuticals AB | $95 million |
| Takeda Pharmaceutical Co. Ltd. | License to Cx601 | $27.7 million |
| Advantage Benefit Solutions | Collins Benefits Solutions, Inc. | Merger |
Schedule a demo
Gain access to the best healthcare and long-term care investment intelligence, data, and analysis.
